{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-052413","form_type":"8-K","ticker":"UNCY","cik":"0001766140","company_name":"Unicycive Therapeutics, Inc.","filed_at":"2025-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.629408+00:00","generated_at":"2026-05-19T17:21:13.789466+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Unicycive shareholders elect four directors and approve reverse stock split at 2025 annual meeting","bullets":["All four director nominees elected: Dr. Aggarwal, Dr. Gupta, Dr. Laumas, Dr. Kenkare-Mitra.","Ratification of Grassi & Co. as independent auditor approved (87.8M for, 531.6K against).","Reverse stock split proposal approved (78.1M for, 9.6M against, 771.4K abstain).","69.7% of total voting power was represented at the meeting (88.4M of 126.9M votes)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-052413","json":"https://secwatch.observer/filing/0001213900-25-052413.json","markdown":"https://secwatch.observer/filing/0001213900-25-052413.md","text":"https://secwatch.observer/filing/0001213900-25-052413.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025052413/0001213900-25-052413-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1766140/000121390025052413/ea0245071-8k_unicycive.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T17:21:13.789466+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}